The background in the peptide sector began long before BioPlex was registered in the UK
Hi topazrat I've been on cyanocobamalin B12 for 45 years and when I was tried on hydroxocobamalin in the 1980s (when it was first introduced) I had similar symptoms to yours and asked to be returned to the cyano
So, um, there was a study looking at, uh, it was, I think, in
In the intestine, FXR stimulates the expression of fibroblast growth factor 15 (FGF15) or FGF19, which in turn inhibits hepatic CYP7A1 gene transcription, thereby directly or indirectly suppressing SREBP1c and aiding in the inhibition of hepatic lipid synthesis (Yamagata et al., 2004)
These dont make the product approved, but they do signal a higher standard in an otherwise inconsistent market